Murphy & Mullick Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08K Hold
20
– – ﹤0.01% 657
2026
Q2
$841 Hold
20
– – ﹤0.01% 642
2026
Q1
$528 Hold
20
– – ﹤0.01% 655
2025
Q4
$579 Hold
20
– – ﹤0.01% 661
2025
Q3
$596 Hold
20
– – ﹤0.01% 641
2025
Q2
$487 Hold
20
– – ﹤0.01% 641
2025
Q1
$415 Hold
20
– – ﹤0.01% 636
2024
Q4
$471 Buy
+20
New +$492 ﹤0.01% 625

Other funds holding ARKG

Murphy & Mullick Capital Management's ARKG Position: Q3 2026 in Review

Murphy & Mullick Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 20 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Murphy & Mullick Capital Management first reported a position in ARKG in Q4 2024 and has held it in 8 quarters since. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Murphy & Mullick Capital Management held 20 shares of ARK Genomic Revolution ETF worth $1.08K as of Q3 2026.
  • Murphy & Mullick Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #657 holding.
  • Murphy & Mullick Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 8 quarters since.
  • 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.